The data revealed that at the time of progression, the close association of SOX10+ melanoma cells with CD8+ T cells negatively correlated with PFS of melanoma patients and may indicate a potential mechanism for acquired resistance to BRAF/MEK-targeted therapy. This evidence concerns the gene CD8A and melanoma.